{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:13:25Z","timestamp":1793502805075,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T00:00:00Z","timestamp":1485734400000},"content-version":"vor","delay-in-days":243,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Sixth Framework Programme of the EU","award":["LSHM-CT-2004-503474"],"award-info":[{"award-number":["LSHM-CT-2004-503474"]}]},{"name":"Sixth Framework Programme of the EU","award":["HRF T03298\/2000"],"award-info":[{"award-number":["HRF T03298\/2000"]}]},{"name":"Hungarian Brain Research Program","award":["KTIA_13_NAP-A-II\/14"],"award-info":[{"award-number":["KTIA_13_NAP-A-II\/14"]}]},{"name":"National Development Agency","award":["KTIA_NAP_13-1-2013-0001"],"award-info":[{"award-number":["KTIA_NAP_13-1-2013-0001"]}]},{"DOI":"10.13039\/501100003825","name":"Hungarian Academy of Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"crossref"}]},{"name":"MTA-SE-NAP B Genetic Brain Imaging Migraine Research Group","award":["KTIA_NAP_13-2-2015-0001"],"award-info":[{"award-number":["KTIA_NAP_13-2-2015-0001"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.euroneuro.2016.03.003","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T17:03:04Z","timestamp":1457542984000},"page":"1020-1028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma"],"prefix":"10.1016","volume":"26","author":[{"given":"Judit","family":"Lazary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Eszlari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Juhasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyorgy","family":"Bagdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2016.03.003_bib1","first-page":"732","article-title":"Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression","volume":"697","author":"Agrawal","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib2","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1161\/01.STR.20.9.1190","article-title":"Comparison of six depression rating scales in geriatric stroke patients","volume":"209","author":"Agrell","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S1461145704004808","article-title":"Exposure to juvenile stress exacerbates the behavioural consequences of exposure to stress in the adult rat","volume":"82","author":"Avital","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00004583-199703000-00012","article-title":"Validity of the childhood trauma questionnaire in an adolescent psychiatric population","volume":"363","author":"Bernstein","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1192\/bjp.132.4.381","article-title":"Validity of the Zung self-rating depression scale","volume":"132","author":"Biggs","year":"1978","journal-title":"Br. J. Psychiatr."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib6","series-title":"Manual for the State-Trait Anxiety Inventory","author":"Spielberger","year":"1970"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib7","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/hmg\/ddh216","article-title":"Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use","volume":"1318","author":"Chiang","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00213-012-2785-y","article-title":"A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional\u2013motivational reactivity","volume":"2244","author":"Conzelmann","year":"2012","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib9","series-title":"BSI Brief Symptom Inventory: Administration, Scoring and Procedure Manual","author":"Derogatis","year":"1993"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib1001","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1021055617738","article-title":"DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping","volume":"33","author":"Freeman","year":"2003","journal-title":"Behav. Genet."},{"issue":"Suppl. 1","key":"10.1016\/j.euroneuro.2016.03.003_bib10","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1111\/j.1365-2826.2008.01670.x","article-title":"Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development","volume":"20","author":"Fride","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nbd.2012.03.012","article-title":"How does the brain deal with cumulative stress? A review with focus on developmental stress, HPA axis function and hippocampal structure in humans","volume":"52","author":"Frodl","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"Pt. 2","key":"10.1016\/j.euroneuro.2016.03.003_bib12","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2466\/pr0.1985.57.3f.1091","article-title":"Reliability, discriminant and predictive validity of the Zung self-rating depression scale","volume":"573","author":"Gabrys","year":"1985","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tips.2013.08.008","article-title":"Amygdala FAAH and anandamide: mediating protection and recovery from stress","volume":"3411","author":"Gunduz-Cinar","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/mp.2012.72","article-title":"Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity","volume":"187","author":"Gunduz-Cinar","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00213-009-1494-7","article-title":"Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats","volume":"2044","author":"Haller","year":"2009","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biopsych.2008.10.047","article-title":"Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function","volume":"661","author":"Hariri","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.biopsych.2007.07.002","article-title":"The dexamethasone\/corticotropin-releasing factor test in men with major depression: role of childhood trauma","volume":"634","author":"Heim","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib18","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1038\/npp.2009.114","article-title":"Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic\u2013pituitary\u2013adrenal axis","volume":"3413","author":"Hill","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2007-993211","article-title":"Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report","volume":"412","author":"Hill","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.npp.1300601","article-title":"Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress","volume":"303","author":"Hill","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroscience.2011.11.020","article-title":"Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence","volume":"204","author":"Hillard","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1476-511X-11-32","article-title":"Serum contents of endocannabinoids are correlated with blood pressure in depressed women","volume":"11","author":"Ho","year":"2012","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib23","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/npp.2009.19","article-title":"CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms","volume":"348","author":"Juhasz","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib24","doi-asserted-by":"crossref","first-page":"e0116316","DOI":"10.1371\/journal.pone.0116316","article-title":"Variability in the effect of 5-HTTLPR on depression in a large European population: the role of age, symptom profile, type and intensity of life stressors","volume":"103","author":"Juhasz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib25","doi-asserted-by":"crossref","first-page":"E1666","DOI":"10.1073\/pnas.1403649111","article-title":"Brain galanin system genes interact with life stresses in depression-related phenotypes","volume":"11116","author":"Juhasz","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archgenpsychiatry.2010.9","article-title":"Increased BDNF promoter methylation in the Wernicke area of suicide subjects","volume":"673","author":"Keller","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1748-1716.2011.02402.x","article-title":"CB1 receptor antagonists: new discoveries leading to new perspectives","volume":"2051","author":"Kirilly","year":"2012","journal-title":"Acta Physiol. (Oxf.)"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00702-012-0900-1","article-title":"Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists","volume":"1201","author":"Kirilly","year":"2013","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.tips.2011.02.013","article-title":"Personalized medicine can pave the way for the safe use of CB(1) receptor antagonists","volume":"325","author":"Lazary","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib30","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/ajmg.b.31024","article-title":"Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with 5-HTTLPR affect the anxious phenotype","volume":"150B8","author":"Lazary","year":"2009","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.phrs.2013.05.001","article-title":"Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure","volume":"74","author":"Llorente-Berzal","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/3-540-26573-2_10","article-title":"Distribution of cannabinoid receptors in the central and peripheral nervous system","volume":"168","author":"Mackie","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/mp.2012.21","article-title":"A mega-analysis of genome-wide association studies for major depressive disorder","volume":"184","author":"Major Depressive Disorder Working Group of the Psychiatric GC","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/FBP.0000000000000068","article-title":"Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain","volume":"255\u2013256","author":"Marco","year":"2014","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib35","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1177\/0269881110370503","article-title":"Adolescent exposure to nicotine and\/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB(1) cannabinoid receptors","volume":"2512","author":"Mateos","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nn.2270","article-title":"Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse","volume":"123","author":"McGowan","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neubiorev.2014.02.006","article-title":"A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior","volume":"42","author":"McLaughlin","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib38","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/mp.2012.145","article-title":"Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity","volume":"1812","author":"Meye","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.phrs.2010.01.002","article-title":"Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression","volume":"615","author":"Monteleone","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuroscience.2011.11.043","article-title":"Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic\u2013pituitary\u2013adrenal axis responses in male Sprague\u2013Dawley rats","volume":"204","author":"Newsom","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib41","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1196\/annals.1369.052","article-title":"Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain","volume":"1074","author":"Onaivi","year":"2006","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib42","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/febs.12260","article-title":"Modulating the endocannabinoid system in human health and disease \u2013 successes and failures","volume":"2809","author":"Pacher","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.npp.1300535","article-title":"Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala","volume":"303","author":"Patel","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fncel.2015.00098","article-title":"Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context","volume":"9","author":"Rivera","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib45","doi-asserted-by":"crossref","first-page":"8394","DOI":"10.1073\/pnas.082235799","article-title":"A missense mutation in human fatty acid amide hydrolase associated with problem drug use","volume":"9912","author":"Sipe","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2016.03.003_bib46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-0327(98)00056-1","article-title":"The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey","volume":"502\u2013503","author":"Szadoczky","year":"1998","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib47","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.biopsych.2004.11.033","article-title":"Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims","volume":"575","author":"Vinod","year":"2005","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib48","doi-asserted-by":"crossref","first-page":"11188","DOI":"10.1523\/JNEUROSCI.1046-10.2010","article-title":"Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus","volume":"3033","author":"Wamsteeker","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/0269881111409606","article-title":"Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation","volume":"261","author":"Wang","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.03.003_bib50","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archpsyc.1965.01730060026004","article-title":"Self-rating depression scale in an outpatient clinic. Further validation of the SDS","volume":"136","author":"Zung","year":"1965","journal-title":"Arch. Gen. Psychiatr."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X16000778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X16000778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T22:50:11Z","timestamp":1600296611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X16000778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0924977X16000778"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2016.03.003","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2016.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}